EW logo

Edwards Lifesciences (EW) Working Capital

EW Annual Working Capital

$2.84 B
+$766.90 M+36.99%

31 December 2023

EW Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

EW Quarterly Working Capital

$4.78 B
+$1.48 B+45.00%

30 September 2024

EW Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

EW Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+37.0%+69.1%
3 y3 years+29.3%+87.7%
5 y5 years+101.4%+143.6%

EW Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+37.0%at high+130.7%
5 y5-yearat high+37.0%at high+171.6%
alltimeall timeat high+4408.4%at high>+9999.0%

Edwards Lifesciences Working Capital History

DateAnnualQuarterly
Sept 2024
-
$4.78 B(+45.0%)
June 2024
-
$3.30 B(+7.8%)
Mar 2024
-
$3.06 B(+7.7%)
Dec 2023
$2.84 B(+37.0%)
$2.84 B(+0.4%)
Sept 2023
-
$2.83 B(+13.6%)
June 2023
-
$2.49 B(+14.5%)
Mar 2023
-
$2.18 B(+4.9%)
Dec 2022
$2.07 B(-3.5%)
$2.07 B(-20.1%)
Sept 2022
-
$2.60 B(+13.2%)
June 2022
-
$2.29 B(+0.1%)
Mar 2022
-
$2.29 B(+6.7%)
Dec 2021
$2.15 B(-2.2%)
$2.15 B(-15.7%)
Sept 2021
-
$2.55 B(+4.6%)
June 2021
-
$2.44 B(+7.3%)
Mar 2021
-
$2.27 B(+3.3%)
Dec 2020
$2.20 B(+5.5%)
$2.20 B(+3.0%)
Sept 2020
-
$2.13 B(+17.4%)
June 2020
-
$1.82 B(+3.2%)
Mar 2020
-
$1.76 B(-15.4%)
Dec 2019
$2.08 B(+47.6%)
$2.08 B(+6.0%)
Sept 2019
-
$1.96 B(+18.5%)
June 2019
-
$1.66 B(-3.8%)
Mar 2019
-
$1.72 B(+22.1%)
Dec 2018
$1.41 B(+24.9%)
$1.41 B(-14.6%)
Sept 2018
-
$1.65 B(+9.2%)
June 2018
-
$1.51 B(+7.9%)
Mar 2018
-
$1.40 B(+24.2%)
Dec 2017
$1.13 B(-33.9%)
$1.13 B(-38.3%)
Sept 2017
-
$1.83 B(+6.4%)
June 2017
-
$1.72 B(+20.0%)
Mar 2017
-
$1.43 B(-16.0%)
Dec 2016
$1.71 B(+8.6%)
$1.71 B(+4.2%)
Sept 2016
-
$1.64 B(+8.7%)
June 2016
-
$1.51 B(+10.7%)
Mar 2016
-
$1.36 B(-13.4%)
Dec 2015
$1.57 B(-12.9%)
$1.57 B(-2.6%)
Sept 2015
-
$1.61 B(-12.9%)
June 2015
-
$1.85 B(+0.1%)
Mar 2015
-
$1.85 B(+2.5%)
Dec 2014
$1.80 B(+30.8%)
$1.80 B(-4.1%)
Sept 2014
-
$1.88 B(+8.3%)
June 2014
-
$1.74 B(+39.3%)
Mar 2014
-
$1.25 B(-9.6%)
Dec 2013
$1.38 B(+46.1%)
$1.38 B(+11.7%)
Sept 2013
-
$1.24 B(+14.8%)
June 2013
-
$1.08 B(+1.5%)
Mar 2013
-
$1.06 B(+12.3%)
Dec 2012
$944.50 M
$944.50 M(-13.3%)
Sept 2012
-
$1.09 B(+9.5%)
June 2012
-
$994.50 M(+7.8%)
DateAnnualQuarterly
Mar 2012
-
$922.80 M(+10.7%)
Dec 2011
$833.30 M(+19.9%)
$833.30 M(-5.3%)
Sept 2011
-
$879.90 M(-2.6%)
June 2011
-
$903.50 M(+28.1%)
Mar 2011
-
$705.10 M(+1.5%)
Dec 2010
$694.80 M(+16.1%)
$694.80 M(+13.9%)
Sept 2010
-
$610.20 M(-9.1%)
June 2010
-
$671.20 M(+6.5%)
Mar 2010
-
$630.50 M(+5.3%)
Dec 2009
$598.70 M(+38.1%)
$598.70 M(+3.1%)
Sept 2009
-
$580.90 M(+16.1%)
June 2009
-
$500.50 M(+11.5%)
Mar 2009
-
$448.80 M(+3.6%)
Dec 2008
$433.40 M(+110.1%)
$433.40 M(-2.9%)
Sept 2008
-
$446.40 M(+9.3%)
June 2008
-
$408.50 M(+104.3%)
Mar 2008
-
$200.00 M(-3.1%)
Dec 2007
$206.30 M(-32.4%)
$206.30 M(-4.5%)
Sept 2007
-
$216.00 M(-0.7%)
June 2007
-
$217.60 M(-40.0%)
Mar 2007
-
$362.70 M(+18.8%)
Dec 2006
$305.40 M(-4.6%)
$305.40 M(+2.7%)
Sept 2006
-
$297.40 M(-5.8%)
June 2006
-
$315.80 M(-4.0%)
Mar 2006
-
$329.00 M(+2.8%)
Dec 2005
$320.00 M(+85.9%)
$320.00 M(+41.7%)
Sept 2005
-
$225.80 M(-8.5%)
June 2005
-
$246.70 M(+10.0%)
Mar 2005
-
$224.20 M(+30.3%)
Dec 2004
$172.10 M(-10.8%)
$172.10 M(+10.4%)
Sept 2004
-
$155.90 M(-12.1%)
June 2004
-
$177.30 M(+4.1%)
Mar 2004
-
$170.30 M(-11.8%)
Dec 2003
$193.00 M(+35.1%)
$193.00 M(-1.7%)
Sept 2003
-
$196.30 M(-2.9%)
June 2003
-
$202.10 M(+25.1%)
Mar 2003
-
$161.50 M(+13.0%)
Dec 2002
$142.90 M(+33.1%)
$142.90 M(+16.8%)
Sept 2002
-
$122.30 M(-2.6%)
June 2002
-
$125.60 M(+5.4%)
Mar 2002
-
$119.20 M(+11.0%)
Dec 2001
$107.40 M(+70.5%)
$107.40 M(-8.6%)
Sept 2001
-
$117.50 M(+0.3%)
June 2001
-
$117.10 M(+51.1%)
Mar 2001
-
$77.50 M(+23.0%)
Dec 2000
$63.00 M(-68.5%)
$63.00 M(<-9900.0%)
Sept 2000
-
-$200.00 K(-99.4%)
June 2000
-
-$36.00 M(+157.1%)
Mar 2000
-
-$14.00 M
Dec 1999
$200.00 M
-

FAQ

  • What is Edwards Lifesciences annual working capital?
  • What is the all time high annual working capital for Edwards Lifesciences?
  • What is Edwards Lifesciences annual working capital year-on-year change?
  • What is Edwards Lifesciences quarterly working capital?
  • What is the all time high quarterly working capital for Edwards Lifesciences?
  • What is Edwards Lifesciences quarterly working capital year-on-year change?

What is Edwards Lifesciences annual working capital?

The current annual working capital of EW is $2.84 B

What is the all time high annual working capital for Edwards Lifesciences?

Edwards Lifesciences all-time high annual working capital is $2.84 B

What is Edwards Lifesciences annual working capital year-on-year change?

Over the past year, EW annual working capital has changed by +$766.90 M (+36.99%)

What is Edwards Lifesciences quarterly working capital?

The current quarterly working capital of EW is $4.78 B

What is the all time high quarterly working capital for Edwards Lifesciences?

Edwards Lifesciences all-time high quarterly working capital is $4.78 B

What is Edwards Lifesciences quarterly working capital year-on-year change?

Over the past year, EW quarterly working capital has changed by +$1.96 B (+69.12%)